- Title
- Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
- Creators - without role
- Franck Morschhauser - Centre Hospitalier Universitaire de LilleMartin J S Dyer - Ernest and Helen Scott Haematological Research InstituteHarriet S Walter - Ernest and Helen Scott Haematological Research InstituteAlexey V Danilov - City Of Hope National Medical CenterLoic Ysebaert - Institut universitaire du cancer de Toulouse OncopoleDaniel James Hodson - University of CambridgeChristopher Fegan - University Hospital of WalesSimon A Rule - University of PlymouthJohn Radford - University of ManchesterGuillaume Cartron - Centre Hospitalier Universitaire de MontpellierKrimo Bouabdallah - Centre Hospitalier Universitaire de BordeauxAndrew John Davies - University of SouthamptonStephen Spurgeon - OHSU Knight Cancer InstituteNishanthan Rajakumaraswamy - Gilead SciencesBiao Li - Gilead SciencesRita Humeniuk - Gilead SciencesXi Huang - Gilead SciencesPankaj Bhargava - Gilead SciencesJuliane M Jürgensmeier - Gilead SciencesGilles Salles - Université Claude Bernard Lyon 1
- Publication Details
- Leukemia
- Identifiers
- 9939536909311
- Academic Unit
- Institut de Génétique Moléculaire de Montpellier - IGMM
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-03176626
Journal article
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
Leukemia
17/12/2020
PMID: 33328591
Metrics
1 Record Views